These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 23074998)

  • 21. Critical role of endogenous thrombospondin-1 in preventing expansion of healing myocardial infarcts.
    Frangogiannis NG; Ren G; Dewald O; Zymek P; Haudek S; Koerting A; Winkelmann K; Michael LH; Lawler J; Entman ML
    Circulation; 2005 Jun; 111(22):2935-42. PubMed ID: 15927970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular evolution of the Thrombospondin superfamily.
    Tucker RP; Adams JC
    Semin Cell Dev Biol; 2024 Mar; 155(Pt B):12-21. PubMed ID: 37202276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential novel pharmacological therapies for myocardial remodelling.
    Landmesser U; Wollert KC; Drexler H
    Cardiovasc Res; 2009 Feb; 81(3):519-27. PubMed ID: 19019834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombospondin-1 modulates angiogenesis in vitro by up-regulation of matrix metalloproteinase-9 in endothelial cells.
    Qian X; Wang TN; Rothman VL; Nicosia RF; Tuszynski GP
    Exp Cell Res; 1997 Sep; 235(2):403-12. PubMed ID: 9299165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In the balance: how do thrombospondins contribute to the cellular pathophysiology of cardiovascular disease?
    Forbes T; Pauza AG; Adams JC
    Am J Physiol Cell Physiol; 2021 Nov; 321(5):C826-C845. PubMed ID: 34495764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thrombospondin-2 is essential for myocardial matrix integrity: increased expression identifies failure-prone cardiac hypertrophy.
    Schroen B; Heymans S; Sharma U; Blankesteijn WM; Pokharel S; Cleutjens JP; Porter JG; Evelo CT; Duisters R; van Leeuwen RE; Janssen BJ; Debets JJ; Smits JF; Daemen MJ; Crijns HJ; Bornstein P; Pinto YM
    Circ Res; 2004 Sep; 95(5):515-22. PubMed ID: 15284191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Control of organization and function of muscle and tendon by thrombospondin-4.
    Frolova EG; Drazba J; Krukovets I; Kostenko V; Blech L; Harry C; Vasanji A; Drumm C; Sul P; Jenniskens GJ; Plow EF; Stenina-Adognravi O
    Matrix Biol; 2014 Jul; 37():35-48. PubMed ID: 24589453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Thrombospondins: multimodular proteins with angiostatic function].
    Feige JJ
    Pathol Biol (Paris); 1999 Apr; 47(4):339-44. PubMed ID: 10372402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular cloning and characterization of Fc-TSP from the Chinese shrimp Fennerpenaeus chinensis.
    Sun YD; Zhao XF; Kang CJ; Wang JX
    Mol Immunol; 2006 Mar; 43(8):1202-10. PubMed ID: 16111753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extracellular matrix and cardiovascular diseases.
    Ju H; Dixon IM
    Can J Cardiol; 1996 Dec; 12(12):1259-67. PubMed ID: 8987966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The build-up of the thrombospondin extracellular matrix. An apparent dependence on synthesis and on preformed fibrillar matrix.
    Dreyfus M; Lahav J
    Eur J Cell Biol; 1988 Dec; 47(2):275-82. PubMed ID: 3072202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of thrombospondins 1 and 2 in the regulation of cell-matrix interactions, collagen fibril formation, and the response to injury.
    Bornstein P; Agah A; Kyriakides TR
    Int J Biochem Cell Biol; 2004 Jun; 36(6):1115-25. PubMed ID: 15094126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombospondin-1: a proatherosclerotic protein augmented by hyperglycemia.
    Maier KG; Han X; Sadowitz B; Gentile KL; Middleton FA; Gahtan V
    J Vasc Surg; 2010 May; 51(5):1238-47. PubMed ID: 20299182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of class A human thrombospondins in the clearance of dying cells and tolerance induction.
    Tabib A; Krispin A; Mevorach D
    Ann N Y Acad Sci; 2010 Oct; 1209():43-8. PubMed ID: 20958315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human carcinoma cells bind thrombospondin through a Mr 80,000/105,000 receptor.
    Yabkowitz R; Dixit VM
    Cancer Res; 1991 Jul; 51(14):3648-56. PubMed ID: 1712244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thrombospondins in the heart: potential functions in cardiac remodeling.
    Schellings MW; van Almen GC; Sage EH; Heymans S
    J Cell Commun Signal; 2009 Dec; 3(3-4):201-13. PubMed ID: 19798592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombospondin mediates migration and potentiates platelet-derived growth factor-dependent migration of calf pulmonary artery smooth muscle cells.
    Yabkowitz R; Mansfield PJ; Ryan US; Suchard SJ
    J Cell Physiol; 1993 Oct; 157(1):24-32. PubMed ID: 8408239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombospondins, metallo proteases and thrombospondin receptors messenger RNA and protein expression in different tumour sublines of the Dunning prostate cancer model.
    Vallbo C; Damber JE
    Acta Oncol; 2005; 44(3):293-8. PubMed ID: 16076702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phylogenomic analysis of vertebrate thrombospondins reveals fish-specific paralogues, ancestral gene relationships and a tetrapod innovation.
    McKenzie P; Chadalavada SC; Bohrer J; Adams JC
    BMC Evol Biol; 2006 Apr; 6():33. PubMed ID: 16620379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth hormone, acromegaly, and heart failure: an intricate triangulation.
    Saccà L; Napoli R; Cittadini A
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):660-71. PubMed ID: 14974906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.